Global Plasma Fractionation and Blood Product Market Growth 2022-2028

Publisher Name :
Date: 17-Jan-2022
No. of pages: 101

As the global economy mends, the 2021 growth of Plasma Fractionation and Blood Product will have significant change from previous year. According to our (LP Information) latest study, the global Plasma Fractionation and Blood Product market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Plasma Fractionation and Blood Product market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Plasma Fractionation and Blood Product market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Plasma Fractionation and Blood Product market, reaching US$ million by the year 2028. As for the Europe Plasma Fractionation and Blood Product landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Plasma Fractionation and Blood Product players cover Takeda, CSL, Grifols, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Fractionation and Blood Product market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

- Coagulation Factor

- Immune Globulin

- Albumin

- Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

- Immunology

- Hematology

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

- Takeda

- CSL

- Grifols

- Octapharma

- Kedrion

- LFB Group

- Biotest

- BPL

- RAAS

- CBPO

- Hualan Bio

Global Plasma Fractionation and Blood Product Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma Fractionation and Blood Product Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Plasma Fractionation and Blood Product by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Plasma Fractionation and Blood Product by Country/Region, 2017, 2022 & 2028
2.2 Plasma Fractionation and Blood Product Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Other
2.3 Plasma Fractionation and Blood Product Sales by Type
2.3.1 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2022)
2.3.2 Global Plasma Fractionation and Blood Product Revenue and Market Share by Type (2017-2022)
2.3.3 Global Plasma Fractionation and Blood Product Sale Price by Type (2017-2022)
2.4 Plasma Fractionation and Blood Product Segment by Application
2.4.1 Immunology
2.4.2 Hematology
2.4.3 Other
2.5 Plasma Fractionation and Blood Product Sales by Application
2.5.1 Global Plasma Fractionation and Blood Product Sale Market Share by Application (2017-2022)
2.5.2 Global Plasma Fractionation and Blood Product Revenue and Market Share by Application (2017-2022)
2.5.3 Global Plasma Fractionation and Blood Product Sale Price by Application (2017-2022)
3 Global Plasma Fractionation and Blood Product by Company
3.1 Global Plasma Fractionation and Blood Product Breakdown Data by Company
3.1.1 Global Plasma Fractionation and Blood Product Annual Sales by Company (2020-2022)
3.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Company (2020-2022)
3.2 Global Plasma Fractionation and Blood Product Annual Revenue by Company (2020-2022)
3.2.1 Global Plasma Fractionation and Blood Product Revenue by Company (2020-2022)
3.2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Company (2020-2022)
3.3 Global Plasma Fractionation and Blood Product Sale Price by Company
3.4 Key Manufacturers Plasma Fractionation and Blood Product Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Fractionation and Blood Product Product Location Distribution
3.4.2 Players Plasma Fractionation and Blood Product Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Plasma Fractionation and Blood Product by Geographic Region
4.1 World Historic Plasma Fractionation and Blood Product Market Size by Geographic Region (2017-2022)
4.1.1 Global Plasma Fractionation and Blood Product Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Plasma Fractionation and Blood Product Annual Revenue by Geographic Region
4.2 World Historic Plasma Fractionation and Blood Product Market Size by Country/Region (2017-2022)
4.2.1 Global Plasma Fractionation and Blood Product Annual Sales by Country/Region (2017-2022)
4.2.2 Global Plasma Fractionation and Blood Product Annual Revenue by Country/Region
4.3 Americas Plasma Fractionation and Blood Product Sales Growth
4.4 APAC Plasma Fractionation and Blood Product Sales Growth
4.5 Europe Plasma Fractionation and Blood Product Sales Growth
4.6 Middle East & Africa Plasma Fractionation and Blood Product Sales Growth
5 Americas
5.1 Americas Plasma Fractionation and Blood Product Sales by Country
5.1.1 Americas Plasma Fractionation and Blood Product Sales by Country (2017-2022)
5.1.2 Americas Plasma Fractionation and Blood Product Revenue by Country (2017-2022)
5.2 Americas Plasma Fractionation and Blood Product Sales by Type
5.3 Americas Plasma Fractionation and Blood Product Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Fractionation and Blood Product Sales by Region
6.1.1 APAC Plasma Fractionation and Blood Product Sales by Region (2017-2022)
6.1.2 APAC Plasma Fractionation and Blood Product Revenue by Region (2017-2022)
6.2 APAC Plasma Fractionation and Blood Product Sales by Type
6.3 APAC Plasma Fractionation and Blood Product Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Plasma Fractionation and Blood Product by Country
7.1.1 Europe Plasma Fractionation and Blood Product Sales by Country (2017-2022)
7.1.2 Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2022)
7.2 Europe Plasma Fractionation and Blood Product Sales by Type
7.3 Europe Plasma Fractionation and Blood Product Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plasma Fractionation and Blood Product by Country
8.1.1 Middle East & Africa Plasma Fractionation and Blood Product Sales by Country (2017-2022)
8.1.2 Middle East & Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2022)
8.2 Middle East & Africa Plasma Fractionation and Blood Product Sales by Type
8.3 Middle East & Africa Plasma Fractionation and Blood Product Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Fractionation and Blood Product
10.3 Manufacturing Process Analysis of Plasma Fractionation and Blood Product
10.4 Industry Chain Structure of Plasma Fractionation and Blood Product
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Fractionation and Blood Product Distributors
11.3 Plasma Fractionation and Blood Product Customer
12 World Forecast Review for Plasma Fractionation and Blood Product by Geographic Region
12.1 Global Plasma Fractionation and Blood Product Market Size Forecast by Region
12.1.1 Global Plasma Fractionation and Blood Product Forecast by Region (2023-2028)
12.1.2 Global Plasma Fractionation and Blood Product Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma Fractionation and Blood Product Forecast by Type
12.7 Global Plasma Fractionation and Blood Product Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma Fractionation and Blood Product Product Offered
13.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Fractionation and Blood Product Product Offered
13.2.3 CSL Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Fractionation and Blood Product Product Offered
13.3.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Fractionation and Blood Product Product Offered
13.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Fractionation and Blood Product Product Offered
13.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Fractionation and Blood Product Product Offered
13.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Fractionation and Blood Product Product Offered
13.7.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Fractionation and Blood Product Product Offered
13.8.3 BPL Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma Fractionation and Blood Product Product Offered
13.9.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Plasma Fractionation and Blood Product Product Offered
13.10.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Plasma Fractionation and Blood Product Product Offered
13.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Plasma Fractionation and Blood Product Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Plasma Fractionation and Blood Product Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Other
Table 7. Global Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 8. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2022)
Table 9. Global Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & ($ million)
Table 10. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2022)
Table 11. Global Plasma Fractionation and Blood Product Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 13. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2022)
Table 14. Global Plasma Fractionation and Blood Product Revenue by Application (2017-2022)
Table 15. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2022)
Table 16. Global Plasma Fractionation and Blood Product Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Plasma Fractionation and Blood Product Sales by Company (2020-2022) & (K Units)
Table 18. Global Plasma Fractionation and Blood Product Sales Market Share by Company (2020-2022)
Table 19. Global Plasma Fractionation and Blood Product Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Plasma Fractionation and Blood Product Revenue Market Share by Company (2020-2022)
Table 21. Global Plasma Fractionation and Blood Product Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Plasma Fractionation and Blood Product Producing Area Distribution and Sales Area
Table 23. Players Plasma Fractionation and Blood Product Products Offered
Table 24. Plasma Fractionation and Blood Product Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Fractionation and Blood Product Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Plasma Fractionation and Blood Product Sales Market Share Geographic Region (2017-2022)
Table 29. Global Plasma Fractionation and Blood Product Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Plasma Fractionation and Blood Product Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Plasma Fractionation and Blood Product Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Plasma Fractionation and Blood Product Sales Market Share by Country/Region (2017-2022)
Table 33. Global Plasma Fractionation and Blood Product Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Plasma Fractionation and Blood Product Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 36. Americas Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2022)
Table 37. Americas Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2022)
Table 39. Americas Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 40. Americas Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2022)
Table 41. Americas Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 42. Americas Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2022)
Table 43. APAC Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 44. APAC Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2022)
Table 45. APAC Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2022)
Table 47. APAC Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 48. APAC Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2022)
Table 49. APAC Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 50. APAC Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2022)
Table 51. Europe Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 52. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2022)
Table 53. Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2022)
Table 55. Europe Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 56. Europe Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2022)
Table 57. Europe Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 58. Europe Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Plasma Fractionation and Blood Product
Table 68. Key Market Challenges & Risks of Plasma Fractionation and Blood Product
Table 69. Key Industry Trends of Plasma Fractionation and Blood Product
Table 70. Plasma Fractionation and Blood Product Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Plasma Fractionation and Blood Product Distributors List
Table 73. Plasma Fractionation and Blood Product Customer List
Table 74. Global Plasma Fractionation and Blood Product Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Plasma Fractionation and Blood Product Sales Market Forecast by Region
Table 76. Global Plasma Fractionation and Blood Product Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Plasma Fractionation and Blood Product Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Plasma Fractionation and Blood Product Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Plasma Fractionation and Blood Product Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Plasma Fractionation and Blood Product Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Plasma Fractionation and Blood Product Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Plasma Fractionation and Blood Product Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Plasma Fractionation and Blood Product Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Plasma Fractionation and Blood Product Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Plasma Fractionation and Blood Product Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Plasma Fractionation and Blood Product Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Plasma Fractionation and Blood Product Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Plasma Fractionation and Blood Product Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Application (2023-2028)
Table 94. Takeda Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Plasma Fractionation and Blood Product Product Offered
Table 96. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Takeda Main Business
Table 98. Takeda Latest Developments
Table 99. CSL Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 100. CSL Plasma Fractionation and Blood Product Product Offered
Table 101. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. CSL Main Business
Table 103. CSL Latest Developments
Table 104. Grifols Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 105. Grifols Plasma Fractionation and Blood Product Product Offered
Table 106. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Grifols Main Business
Table 108. Grifols Latest Developments
Table 109. Octapharma Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 110. Octapharma Plasma Fractionation and Blood Product Product Offered
Table 111. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Octapharma Main Business
Table 113. Octapharma Latest Developments
Table 114. Kedrion Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 115. Kedrion Plasma Fractionation and Blood Product Product Offered
Table 116. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Kedrion Main Business
Table 118. Kedrion Latest Developments
Table 119. LFB Group Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 120. LFB Group Plasma Fractionation and Blood Product Product Offered
Table 121. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. LFB Group Main Business
Table 123. LFB Group Latest Developments
Table 124. Biotest Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 125. Biotest Plasma Fractionation and Blood Product Product Offered
Table 126. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Biotest Main Business
Table 128. Biotest Latest Developments
Table 129. BPL Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 130. BPL Plasma Fractionation and Blood Product Product Offered
Table 131. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. BPL Main Business
Table 133. BPL Latest Developments
Table 134. RAAS Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 135. RAAS Plasma Fractionation and Blood Product Product Offered
Table 136. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. RAAS Main Business
Table 138. RAAS Latest Developments
Table 139. CBPO Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 140. CBPO Plasma Fractionation and Blood Product Product Offered
Table 141. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. CBPO Main Business
Table 143. CBPO Latest Developments
Table 144. Hualan Bio Basic Information, Plasma Fractionation and Blood Product Manufacturing Base, Sales Area and Its Competitors
Table 145. Hualan Bio Plasma Fractionation and Blood Product Product Offered
Table 146. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Hualan Bio Main Business
Table 148. Hualan Bio Latest Developments
List of Figures
Figure 1. Picture of Plasma Fractionation and Blood Product
Figure 2. Plasma Fractionation and Blood Product Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Fractionation and Blood Product Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Plasma Fractionation and Blood Product Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Plasma Fractionation and Blood Product Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Coagulation Factor
Figure 10. Product Picture of Immune Globulin
Figure 11. Product Picture of Albumin
Figure 12. Product Picture of Other
Figure 13. Global Plasma Fractionation and Blood Product Sales Market Share by Type in 2021
Figure 14. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2022)
Figure 15. Plasma Fractionation and Blood Product Consumed in Immunology
Figure 16. Global Plasma Fractionation and Blood Product Market: Immunology (2017-2022) & (K Units)
Figure 17. Plasma Fractionation and Blood Product Consumed in Hematology
Figure 18. Global Plasma Fractionation and Blood Product Market: Hematology (2017-2022) & (K Units)
Figure 19. Plasma Fractionation and Blood Product Consumed in Other
Figure 20. Global Plasma Fractionation and Blood Product Market: Other (2017-2022) & (K Units)
Figure 21. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2022)
Figure 22. Global Plasma Fractionation and Blood Product Revenue Market Share by Application in 2021
Figure 23. Plasma Fractionation and Blood Product Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Plasma Fractionation and Blood Product Revenue Market Share by Company in 2021
Figure 25. Global Plasma Fractionation and Blood Product Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Plasma Fractionation and Blood Product Revenue Market Share by Geographic Region in 2021
Figure 27. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2022)
Figure 28. Global Plasma Fractionation and Blood Product Revenue Market Share by Country/Region in 2021
Figure 29. Americas Plasma Fractionation and Blood Product Sales 2017-2022 (K Units)
Figure 30. Americas Plasma Fractionation and Blood Product Revenue 2017-2022 ($ Millions)
Figure 31. APAC Plasma Fractionation and Blood Product Sales 2017-2022 (K Units)
Figure 32. APAC Plasma Fractionation and Blood Product Revenue 2017-2022 ($ Millions)
Figure 33. Europe Plasma Fractionation and Blood Product Sales 2017-2022 (K Units)
Figure 34. Europe Plasma Fractionation and Blood Product Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Plasma Fractionation and Blood Product Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Plasma Fractionation and Blood Product Revenue 2017-2022 ($ Millions)
Figure 37. Americas Plasma Fractionation and Blood Product Sales Market Share by Country in 2021
Figure 38. Americas Plasma Fractionation and Blood Product Revenue Market Share by Country in 2021
Figure 39. United States Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Plasma Fractionation and Blood Product Sales Market Share by Region in 2021
Figure 44. APAC Plasma Fractionation and Blood Product Revenue Market Share by Regions in 2021
Figure 45. China Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Plasma Fractionation and Blood Product Sales Market Share by Country in 2021
Figure 52. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country in 2021
Figure 53. Germany Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Plasma Fractionation and Blood Product Revenue Market Share by Country in 2021
Figure 60. Egypt Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Plasma Fractionation and Blood Product Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Plasma Fractionation and Blood Product in 2021
Figure 66. Manufacturing Process Analysis of Plasma Fractionation and Blood Product
Figure 67. Industry Chain Structure of Plasma Fractionation and Blood Product
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs